The aim of this study was to investigate the microRNA (miRNA) expression pattern in neutrophils from rheumatoid arthritis (RA) patients and its contribution to their pathogenic profile and to ana-lyze the effect of specific autoantibodies or inflammatory components in the regulation of miRNA in RA neutrophils and its modulation by biological therapies. Neutrophils were isolated from paired peripheral blood (PB) and synovial fluid samples of 40 patients with RA and from PB of 40 healthy donors. A miRNA array was performed using nCounter technology. Neutrophils from healthy donors were treated in vitro with antibodies to cit-rullinated protein antigens isolated from RA patients and tumor necrosis factor-alpha (TNF-alpha) or interleukin-6. A number of cytokines and chemokines were analyzed. In vitro treatments of RA-neutrophils with tocilizumab or infliximab were carried out. Transfections with pre-miRNA and DICER downregulation experiments were further performed. RA-neutrophils showed a global downregulation of miRNA and genes involved in their bio-genesis, alongside with an upregulation of various potential mRNA targets related to migration and inflammation. Decreased levels of miRNA and DICER correlated with autoimmunity, inflammation and disease activity. Citrullinated protein antigens and TNF-alpha decreased the expression of numerous miRNA and their biogenesis-related genes, increasing their potential mRNA targets. Infliximab reversed those effects. Transfections with pre-miRNA-223,-126 and-148a specifically modulated genes regulat-ing inflammation, survival and migration whereas DICER depletion influ-enced the inflammatory profile of neutrophils. Taken together RA-neu-trophils exhibited a global low abundance of miRNA induced by autoanti-bodies and inflammatory markers, which potentially contributed to their pathogenic activation. miRNA biogenesis was significantly impaired in RA-neutrophils and further associated with a greater downregulation of miRNA mainly related to migration and inflammation in synovial fluid neu-trophils. Finally, anti-TNF-alpha and anti-interleukin-6 receptor treatments can modulate miRNA levels in the neutrophils, minimizing their inflammatory profile.

Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies

Cecchi, Irene;
2020-01-01

Abstract

The aim of this study was to investigate the microRNA (miRNA) expression pattern in neutrophils from rheumatoid arthritis (RA) patients and its contribution to their pathogenic profile and to ana-lyze the effect of specific autoantibodies or inflammatory components in the regulation of miRNA in RA neutrophils and its modulation by biological therapies. Neutrophils were isolated from paired peripheral blood (PB) and synovial fluid samples of 40 patients with RA and from PB of 40 healthy donors. A miRNA array was performed using nCounter technology. Neutrophils from healthy donors were treated in vitro with antibodies to cit-rullinated protein antigens isolated from RA patients and tumor necrosis factor-alpha (TNF-alpha) or interleukin-6. A number of cytokines and chemokines were analyzed. In vitro treatments of RA-neutrophils with tocilizumab or infliximab were carried out. Transfections with pre-miRNA and DICER downregulation experiments were further performed. RA-neutrophils showed a global downregulation of miRNA and genes involved in their bio-genesis, alongside with an upregulation of various potential mRNA targets related to migration and inflammation. Decreased levels of miRNA and DICER correlated with autoimmunity, inflammation and disease activity. Citrullinated protein antigens and TNF-alpha decreased the expression of numerous miRNA and their biogenesis-related genes, increasing their potential mRNA targets. Infliximab reversed those effects. Transfections with pre-miRNA-223,-126 and-148a specifically modulated genes regulat-ing inflammation, survival and migration whereas DICER depletion influ-enced the inflammatory profile of neutrophils. Taken together RA-neu-trophils exhibited a global low abundance of miRNA induced by autoanti-bodies and inflammatory markers, which potentially contributed to their pathogenic activation. miRNA biogenesis was significantly impaired in RA-neutrophils and further associated with a greater downregulation of miRNA mainly related to migration and inflammation in synovial fluid neu-trophils. Finally, anti-TNF-alpha and anti-interleukin-6 receptor treatments can modulate miRNA levels in the neutrophils, minimizing their inflammatory profile.
2020
105
9
2250
2261
Biological Therapy; Humans; Neutrophils; Tumor Necrosis Factor-alpha; Arthritis, Rheumatoid; MicroRNAs
De la Rosa, Ivan Arias; Perez-Sanchez, Carlos; Ruiz-Limon, Patricia; Patiño-Trives, Alejandra; Torres-Granados, Carmen; Jimenez-Gomez, Yolanda; Del Carmen Abalos-Aguilera, Maria; Cecchi, Irene; Ortega, Rafaela; Caracuel, Miguel Angel; Calvo-Gutierrez, Jerusalem; Escudero-Contreras, Alejandro; Collantes-Estevez, Eduardo; Lopez-Pedrera, Chary; Barbarroja, Nuria
File in questo prodotto:
File Dimensione Formato  
Impaired microRNA in RA Arias De La Rosa EDITORIAL PDF.pdf

Accesso aperto

Dimensione 2.12 MB
Formato Adobe PDF
2.12 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1880103
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact